Voluntis and Bristol-Myers Squibb to Co-Develop Digital Therapeutics for Oncology
Go back to Voluntis and Bristol-Myers Squibb to Co-Develop Digital Therapeutics for Oncology| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 61.15 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.15 | 52 Week High | $77.12 | |||
| Open | $61.15 | 52 Week Low | $49.03 | |||
| Day High | $61.15 | P/E | 39.71 | |||
| Day Low | $61.15 | EPS | $1.54 | |||
| Volume | 5,395 | |||||
| CV Therapeutics, Inc. (NASDAQ: VTX) | Delayed: 0.25 -0.06 (19.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.31 | 52 Week High | $0.54 | |||
| Open | $0.34 | 52 Week Low | $0.14 | |||
| Day High | $0.54 | P/E | N/A | |||
| Day Low | $0.14 | EPS | $-2.65 | |||
| Volume | 660,398 | |||||
